Clinical Trials Sponsored by National Cancer Institute, Milan

Total 22242 results

National Cancer Institute (NCI)

Completed

Human Papillomavirus Epidemiology in Nigeria

Cervical Intraepithelial Neoplasia | Uterine Cervical Neoplasms | Human Papillomavirus 16 | Human Papillomavirus 18

Nigeria
National Cancer Institute (NCI)

Completed

Sorafenib and Bevacizumab to Treat Ovarian, Fallopian and Peritoneal Cancer

Fallopian Tube Cancer | Primary Peritoneal Cancer | Ovarian Neoplasm

United States
National Cancer Institute (NCI)

Completed

Benign Reproductive Tissue Analysis for Endometrial Cancer Markers

Hysterectomy | Oophorectomy for Benign Reasons

United States
National Cancer Institute (NCI)

Completed

Studying Blood Toxicity in Workers Exposed to Formaldehyde

Blood | Chemical Industry

China
National Cancer Institute (NCI)

Completed

Continuation of Follow-up of DES-Exposed Cohorts

Breast Cancer | Ovarian Cancer | Prostate Cancer | Endometrial Cancer | Autoimmune Disease

United States
National Cancer Institute (NCI)

Completed

Anal Cancer Screening Study

Anal Cancer

United States
National Cancer Institute (NCI)

Completed

Tocilizumab for KSHV-Associated Multicentric Castleman Disease

Castleman Disease | Multicentric Castleman Disease | Giant Lymph Node Hyperplasia

United States
National Cancer Institute (NCI)

Completed

Interdisciplinary Case-Control Study of Bladder Cancer in Spain

Bladder Cancer

Spain
National Cancer Institute (NCI)

Completed

Eligibility Screening for a NCI Pediatric Oncology Branch Research Study

Osteosarcoma | Acute Lymphoblastic Leukemia | Ewing Sarcoma | Neurofibromatosis Type 1 | Neuroblastoma

United States
National Cancer Institute (NCI)

Completed

Molecular Profiling of Stage II and III Breast Cancer in Latin American Women Receiving Standard-of-Care Treatment

Breast Cancer

Mexico, Argentina, Brazil, Chile, Uruguay
National Cancer Institute (NCI)

Withdrawn

Biospecimen Procurement for Immunological Landscape Studies Following Hematopoietic Cell Transplantation

Hematopoietic Stem Cell Transplantation | Hematologic Malignancies | Cell Transplantation

United States
National Cancer Institute (NCI)

Completed

Evaluation, Treatment, and Natural History of Children and Young Adults With Cancer or Rare Diseases

Lymphoma | Leukemia | Brain Tumors | Rhabdomyosarcoma | Ewing's Sarcoma

United States
National Cancer Institute (NCI)

Completed

Multi-Targeted Recombinant Ad5 (CEA/MUC1/Brachyury) Based Immunotherapy Vaccine Regimen in People With Advanced Cancer

Neoplasms | Breast Cancer | Lung Cancer | Prostate Cancer | Colon Cancer

United States
National Cancer Institute (NCI)

Completed

Preliminary Study of Endometrial Hyperplasia Groundwork for a Study to Define Precursors of Endometrial Cancer

Endometrial Hyperplasia | Endometrial Cancer | Vaginal Bleeding | Postmenopausal Bleeding

United States
National Cancer Institute (NCI)

Completed

Study of Health Effects of Cosmetic Breast Augmentation

Breast Cancer | Lung Cancer | Suicide | Brain Cancer

United States
National Cancer Institute (NCI)

Completed

Genetic Aspects of Chordoma: A Collaboration With SEER Registries to Identify Chordoma Families

Chordoma

United States
National Cancer Institute (NCI)

Completed

Assessment of Blood Vessel Density in Kaposi's Sarcoma Lesions

Kaposi's Sarcoma

United States
National Cancer Institute (NCI)

Completed

Family Study of Melanoma in Italy

Melanoma | Dysplastic Nevi | Melanocytic Nevi

Spain, Italy
National Cancer Institute (NCI)

Completed

Molecular Epidemiology of Cutaneous Malignant Melanoma

Melanoma

United States
National Cancer Institute (NCI)

Completed

Follow-Up Study of Kidney Cancer Patients

Renal Cancer

Czechia, Poland
National Cancer Institute (NCI)

Completed

Evaluation of Skin, Colonic, and Oral Microbiome and Effect of Time and Antibiotic Treatment on Organism Diversity at Each Site

BMI | General Demographics Characteristics

Costa Rica
National Cancer Institute (NCI)

Terminated

Defining the Clinical Utility of EBV Antibody Screening to Identify Individuals Susceptible to Nasopharyngeal Carcinoma (NPC) Within High-Risk, Multiplex NPC Families

Nasopharyngeal Neoplasms

China
National Cancer Institute (NCI)

Completed

Early Detection of Barrett's Esophagus

Barrett's Esophagus

United States
National Cancer Institute (NCI)

Completed

Intraprostatic Androgenicity in Relation to Circulating Levels of Hormones and Polymorphisms of Hormone-Related Genes: A Methodologic Study

Prostate

United States, China
National Cancer Institute (NCI)

Terminated

NCI UNC Project ESCC

Esophageal Squamous Cell Carcinoma

Malawi
National Cancer Institute (NCI)

Completed

DNA Repair, p53 and Apoptosis Phenotypes in Lung Cancer

Lung Neoplasms

United States
National Cancer Institute (NCI)

Completed

Pilot Study of Educational Interventions in Pediatric Hematopoietic Stem Cell Donors to Increase Knowledge of Donation and Transplantation Procedures

Normal Donors

United States
National Cancer Institute (NCI)

Completed

Study of Plexiform Neurofibromas in Neurofibromatosis Type 1

Plexiform Neurofibromas | NF1

United States
National Cancer Institute (NCI)

Completed

Breast Cancer, Breast Disease, and Pesticides

Breast Cancer

United States
National Cancer Institute (NCI)

Completed

Studying Normal Breast Tissue and Cancer Risk

Neoplasms | Skin Diseases | Neoplasms by Site | Breast Neoplasms | Breast Diseases

United States
National Cancer Institute (NCI)

Completed

Cancer Risk in Organ Transplant Recipients and End-Stage Renal Disease

Cancer | Organ Transplantation | Immunocompromised Host

United States
National Cancer Institute (NCI)

Completed

Early Life Exposures in Agriculture

Lymphoma | Leukemia | Brain Cancer | Testicular Cancer

United States
National Cancer Institute (NCI)

Completed

Premenopausal Hormone Concentrations in a Population of Women at Very Low Risk of Breast Cancer

Menopause | Normal Physiology

Mongolia
National Cancer Institute (NCI)

Completed

Cancer Risk in X-Ray Technologists: Second Survey

Radiation-Induced Neoplasms | Breast+Neoplasm+Radiation+Etiology | Thyroid+Neoplasm+Radiation+Etiology

United States
National Cancer Institute (NCI)

Completed

Bone Mineral Density and Subsequent Cancer Risk

Breast Cancer | Endometrial Cancer

United States
National Cancer Institute (NCI)

Withdrawn

Vancomycin in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLC) Oral

Hepatocellular Carcinoma | Metastatic Hepatocellular Carcinoma

United States
National Cancer Institute (NCI)

Completed

Cervical Cancer Early Endpoints and Determinants

Cervical Cancer | CIN | Neoplasia | Cervical Intraepithelial

United States
National Cancer Institute (NCI)

Completed

Pilot and Feasibility Study of Reduced-Intensity Hematopoietic Stem Cell Transplant for MonoMAC

MDS | Immunodeficiency | GATA2

United States
National Cancer Institute (NCI)

Completed

Diet and Nutrition Pilot Study for Chinese Adolescents and Their Mothers

Physical Activity | Body Composition | Puberty | Methylation

China
National Cancer Institute (NCI)

Terminated

Pilot Study of Allogeneic Tumor Cell Vaccine With Metronomic Oral Cyclophosphamide and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers, Thymic Neoplasms, and Malignant Pleural Mesotheliomas

Sarcoma | Esophageal Cancer | Thymic Carcinoma | Lung Cancer | Malignant Pleural Mesothelioma

United States
National Cancer Institute (NCI)

Completed

Recontacting Participants in the Observing Protein and Energy Nutrition (OPEN) Study: Re-OPEN

Diet | Diet Surveys

United States
National Cancer Institute (NCI)

Completed

Scientific Protocol for the Study of Leukemia and Other Hematologic Diseases Among Clean-up Workers in Ukraine Following the Chernobyl Accident

Leukemia

Ukraine
National Cancer Institute (NCI)

Terminated

Von Hippel-Lindau Disease Genetic Epidemiology Study

Kidney Neoplasms | Von Hippel Lindau Disease

United States
National Cancer Institute (NCI)

Completed

A Multi-Histology Phase II Study of 5-Fluoro-2'-Deoxycytidine With Tetrahydrouridine (FdCyd + THU)

Breast Neoplasms | Head and Neck Neoplasms | Lung Neoplasms | Urinary Bladder Neoplasms

United States
National Cancer Institute (NCI)

Completed

AZD6244 With Cetuximab for Solid Tumors and Colorectal Cancer

Colon Cancer | Colonic Neoplasms | Colonic Cancer | Cancer of the Colon | Colon Neoplasms

United States
National Cancer Institute (NCI)

Terminated

Amatuximab for High Mesothelin Cancers

Carcinoma, Non-Small-Cell Lung | Ovarian Neoplasms | Mesothelioma | Carcinoma, Pancreatic Ductal

United States
National Cancer Institute (NCI)

Terminated

A Pilot Study of F-18 Paclitaxel (FPAC) PET for Evaluating Drug Delivery of Solid Tumors in Breast, Lung, Renal, and Adrenal Cancers

Breast Cancer | Lung Cancer | Renal Cancer | Adrenal Cancer

United States
National Cancer Institute (NCI)

Terminated

Relationship of Genetic Differences to the Development of Chromosome Abnormalities

Radiation Exposure

Russian Federation
National Cancer Institute (NCI)

Completed

A Phase I Trial of Nelfinavir (Viracept ) in Adults With Solid Tumors

Solid Tumors

United States
National Cancer Institute (NCI)

Terminated

-02341066 and PF-00299804 for Advanced Non-Small Cell Lung Cancer

Adenocarcinoma | Carcinoma, Squamous Cell | Carcinoma, Non-Small Cell Lung | Carcinoma, Large Cell

United States

Clinical Trials Sponsored by National Cancer Institute, Milan

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Netherlands

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations